During the World Congress of Nephrology 2025, held at Yashobhoomi, Delhi, from February 6 to 9, a research poster was presented focusing on the prevalence of sarcopenia among individuals with Type 2 diabetes and Chronic Kidney Disease. The study explored the significant impact of muscle loss in this patient population, shedding light on the intricate relationship between diabetes, kidney function, and muscle health. The findings emphasized the need for early detection, targeted interventions, and multidisciplinary management approaches to improve patient outcomes and quality of life.
